Swiss drugmaker Roche is reviewing all future investments in Germany over healthcare cost-cutting ​policies, the company's Germany chief said in ‌an interview with newspaper Welt that was published on Monday.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in